drugset / Trial / NCT00119886

Botox on Vulvar Vestibulitis

NCT00119886

Phase 4 Unknown 64 enrolled Rigshospitalet, Denmark
RandomizedSingle-groupDouble-blindTreatment

Summary

The study seeks to evaluate the effect of botulinum toxin on vulvar vestibulitis (VVS) after local injection with Botox, a potential treatment to relieve patients of vulvar pain, reducing the need for painkillers, and improving the sexual quality of life of the patients.

Timeline

Start
2005-04
Primary completion
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin Protein / enzyme biologic Other